Table 1 Characteristics of pancreatic cancer cases and matched controls at the time of prediagnosis CT imaging

From: Adipose tissue and skeletal muscle wasting precede clinical diagnosis of pancreatic cancer

Characteristica

Cases (N = 714)

Controls (N = 1748)

P value

Age, yearsb

67.1 (10.2)

66.8 (10.3)

0.49

Year of CT scanb

  

0.39

    2003–2010

314 (44)

736 (42)

 

    2011–2017

400 (56)

1012 (58)

 

Intravenous contrast with CT imagingb

563 (79)

1409 (81)

0.32

Femaleb

340 (48)

827 (47)

0.89

Raceb

  

0.63

    White

659 (92)

1603 (92)

 

    Black

55 (8)

145 (8)

 

Study siteb

  

0.53

    DFCI/MGB

228 (32)

581 (33)

 

    KPNC

486 (68)

1167 (67)

 

Body mass index, kg/m2c

29.3 (6.1)

28.9 (6.5)

0.11

Diabetes

193 (27)

368 (21)

0.001

Cigarette Smoking

  

<0.0001

    Never

276 (39)

772 (44)

 

    Past

242 (34)

674 (39)

 

    Current

119 (17)

199 (11)

 

    Unknown

77 (11)

103 (6)

 

History of alcohol use

  

0.44

    No/Unknown

638 (89)

1591 (91)

 

    Yes

76 (11)

157 (9)

 

Prior personal history of cancer

109 (15)

177 (10)

0.0003

Time from prior cancer to prediagnosis scan, years

12.7 (7.8)

11.0 (6.6)

0.06

Indication for CT imaging

   

    Symptoms/suspected conditions of the GI system

108 (15)

189 (11)

0.003

    Symptoms/suspected conditions unrelated to the GI system

164 (23)

548 (31)

<0.0001

    Systemic symptoms

65 (9)

160 (9)

0.97

    New-onset diabetes

4 (1)

6 (0.3)

0.44

    Pain

365 (51)

922 (53)

0.46

    Other/unknown

190 (27)

361 (21)

0.001

Age at pancreatic cancer diagnosis, years

69.4 (10.3)

NA

NA

Pancreatic cancer diagnosis period

  

NA

    2004–2008

108 (15)

NA

 

    2009–2013

281 (39)

NA

 

    2014–2018

325 (46)

NA

 

Pancreatic cancer stage at diagnosis

  

NA

    Non-metastatic

370 (52)

  

    Metastatic

326 (46)

NA

 

    Unknown

18 (3)

NA

 

Mean time from prediagnosis CT imaging to pathological diagnosis, months

22.7 (17.2)

NA

NA

Mean time from at-diagnosis CT imaging to pathological diagnosis, daysd

10 (14)

NA

NA

  1. P values were calculated using chi-square tests for categorical, and two-sided Wilcoxon rank-sum test for continuous variables.
  2. CT computed tomography, DFCI/MGB Dana–Farber Cancer Institute/Mass General Brigham, GI gastrointestinal, KPNC Kaiser Permanente Northern California, NA not applicable.
  3. aCharacteristics obtained at the time of the prediagnosis CT imaging study in cases and matched controls. Mean (standard deviation) for continuous variables and N (%) for categorical variables, unless noted otherwise.
  4. bMatching factors.
  5. cAmong 518 cases and 1628 matched controls with available body mass index at the time of prediagnosis CT imaging.
  6. dAmong 529 cases with available at-diagnosis CT imaging.